The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.55
Ask: 1.85
Change: 0.00 (0.00%)
Spread: 0.30 (19.355%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
LSAA Live PriceLast checked at -
Life Settlement Assets A is an Investment Trust

To generate long-term returns for investors by investing in the life settlement market.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re agreement to reduce performance fee

30 Jun 2022 07:00

RNS Number : 7164Q
Life Settlement Assets PLC
30 June 2022
 

 

LIFE SETTLEMENT ASSETS PLC (the "Company" or "LSA")

AGREEMENT OF REDUCED ACL PERFORMANCE FEE

30 June 2022

As referred to in the Company's annual results for the year ended 31 December 2021, LSA has been in discussions with Acheron Capital Limited ("ACL") regarding the re-negotiation of the performance fee payable to ACL, which is currently defined as an amount equal to 20% of the total distributions made by the Company over an agreed hurdle rate. Agreement has now been reached with ACL that once the current litigation process with one of the policy trustees has been resolved, which is expected to occur during 2022, the performance fee will be reduced from 20% as described above to 10% over the existing hurdle rate.

The resolution of the legal dispute is expected to be accompanied by a judicially approved sale of the policies in the relevant trustee portfolio. The completion of such a sale process, including LSA`s participation therein whether successful or not, would mark the end of LSA`s need to accumulate cash to purchase the relevant policies, so enabling LSA to resume further distributions to Shareholders. Assuming resolution of the dispute, following the first such distribution LSA has agreed to make a one-off payment to ACL of any accrued performance fee payable to ACL held by the Company in excess of $1m, based on the 2022 financial results and subject to the cash requirements of the business. As at 31 December 2021 the accrued performance fee stood at $2.8m. However, in acknowledgement of the significant work that ACL has had to perform with regard to engagement with the legal dispute over a long period, the Directors of LSA have agreed to make an immediate advance to ACL, subject to an agreed clawback mechanism, of $0.5m which will be credited against any amount to be paid under the above one-off payment arrangement, following the publication of the 2022 financial results.

 

For further information contact

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Robert Finlay

020 7408 4090

 

ISCA Administration Services Limited

Company Secretary

Tel: 01392 487056

 

Notes to Editors

Life Settlement Assets PLC is a closed-ended investment trust company which invests in, and manages, portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company seeks to generate long-term returns for investors by investing in the life settlement market, through each of the separate Share Classes. The Company aims to manage its investment in portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSEAFWUEESEFM
Date   Source Headline
15th Dec 202110:07 amRNSNet Asset Value(s)
1st Nov 202112:33 pmRNSNet Asset Value(s)
18th Oct 202110:48 amRNSDividend Declaration
15th Oct 202112:22 pmRNSNet Asset Value(s)
27th Sep 20217:00 amRNSHalf-year Report
10th Aug 202111:03 amRNSNet Asset Value(s)
2nd Jul 202112:55 pmRNSDirector/PDMR Shareholding
1st Jul 202111:45 amRNSDirector/PDMR Shareholding
30th Jun 202110:37 amRNSNet Asset Value(s)
16th Jun 20211:52 pmRNSResult of AGM
10th Jun 202111:50 amRNSHolding(s) in Company
3rd Jun 20214:19 pmRNSTotal Voting Rights
3rd Jun 20214:19 pmRNSHolding(s) in Company
2nd Jun 20215:01 pmRNSCapital Reorganisation Following Share Merger
1st Jun 202110:51 amRNSHolding(s) in Company
28th May 20213:17 pmRNSDividend Confirmation
28th May 20212:09 pmRNSNet Asset Value(s)
26th May 20211:02 pmRNSResult of Meeting - General and Share Class
26th May 202112:56 pmRNSHolding(s) in Company
25th May 20217:00 amRNSTimetable Correction
10th May 202112:08 pmRNSNet Asset Value(s)
30th Apr 20217:00 amRNSPublication of circular and notice of GM
30th Apr 20217:00 amRNSAnnual Financial Report
1st Apr 20213:01 pmRNSNet Asset Value(s)
26th Mar 20211:08 pmRNSHolding(s) in Company
4th Mar 202111:53 amRNSNet Asset Value(s)
16th Feb 20211:26 pmRNSNet Asset Value(s)
14th Jan 20213:08 pmRNSNet Asset Value(s)
31st Dec 202011:36 amRNSConfirmation of Directorate Change
22nd Dec 20207:00 amRNSDirectorate Change and new Board structure
4th Dec 20205:55 pmRNSHolding(s) in Company
2nd Dec 20206:05 pmRNSNet Asset Value(s)
2nd Dec 20205:09 pmRNSHolding(s) in Company
4th Nov 20201:10 pmRNSNet Asset Value(s)
29th Oct 20202:07 pmRNSSecond Price Monitoring Extn
29th Oct 20202:01 pmRNSPrice Monitoring Extension
22nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:36 pmRNSPrice Monitoring Extension
19th Oct 202011:08 amRNSSecond Price Monitoring Extn
19th Oct 202011:01 amRNSPrice Monitoring Extension
7th Oct 20204:48 pmRNSConfirmation of Directorate Change
1st Oct 202012:10 pmRNSNet Asset Value(s)
28th Sep 20207:00 amRNSHalf-year Report
28th Aug 20204:43 pmRNSNet Asset Value(s)
11th Aug 20202:43 pmRNSNet Asset Value(s)
28th Jul 20202:24 pmRNSCorporate Presentation
2nd Jul 20201:30 pmRNSResult of Meeting - Class B Shareholders
2nd Jul 20207:00 amRNSNet Asset Value(s)
17th Jun 20203:10 pmRNSResult of AGM
5th Jun 20204:19 pmRNSAnnual General and Class Meeting Arrangements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.